Long-term protection against HIV-1 infection conferred by tat or rev antisense RNA was affected by the design of the retroviral vector

Virology

Volumn 220, Issue 2, 1996, Pages 377-389

  Peng, Hairong ^a   Callison, Deborah ^a   Li, Peng ^a   Burrell, Christopher ^a,b  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA; REV PROTEIN; TRANSACTIVATOR PROTEIN; VIRUS VECTOR;

ARTICLE; CONTROLLED STUDY; GENE THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0029954702     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0326     Document Type: Article

References (69)

1. Adachi, A., Gendelman, H. E., Koenig, S., Folks, T., Willey, R., Rabson, A., and Martin, M. A. (1986). Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59, 284-291.
2. 1 gene. Nucleic Acids Res. 12, 1101-1115.
3. Bahner, I., Zhou, C., Yu, X-J., Hao, Q-L., Guatelli, J. C., and Kohn, D. B. (1993). Comparison of trans-dominant inhibitory mutant human immunodeficiency virus type 1 genes expressed by retroviral vectors in human T lymphocytes. J. Virol. 67, 3199-3207.
4. Bevec, D., Dobrovnik, M., Hauber, J., and Böhnlein, E. (1992). Inhibition of human immunodeficiency virus type 1 replication in human T cells by retroviral-mediated gene transfer of a dominant-negative rev transactivator. Proc. Natl. Acad. Sci. USA 89, 9870-9874.
5. Chatterjee, S., Johnson, P. R., and Wong, K. K., Jr. (1992). Dual-target inhibition of HIV-1 in vitro by means of an adeno-associated virus antisense vector. Science 258, 1485-1488.
6. Chen, S-Y., Khouri, Y., Bagley, J., and Marasco, W. A. (1994). Combined intra- and extra-cellular immunization against human immunodeficiency virus type 1 infection with a human anti-gp 120 antibody. Proc. Natl. Acad. Sci. USA 91, 5932-5936.
7. Chirmule, N., Than, S., Khan, S. A., and Pahwa, S. (1995). Human immunodeficiency virus tat induces functional unresponsiveness in T cells. J. Virol. 69, 492-498.
8. Chomczynski, P., and Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
9. Crisell, P., Thompson, S., and James, W. (1993). Inhibition of HIV-1 replication by ribozymes that show poor activity in vitro. Nucleic Acids Res. 21, 5251-5255.
10. Cullen, B. R., Lomedico, P. L., and Ju, G. (1984). Transcriptional interference in avian retroviruses - implications for the promoter insertion model of leukaemogenesis. Nature 307, 241-245.
11. Cupp, C., Taylor, J. P., Khalili, K., and Amini, S. (1993). Evidence for stimulation of the transforming growth factor β1 promoter by HIV-1 tat in cells derived from CNS. Oncogene 8, 2231-2236.
12. Dayton, A. I., Sodroski, J. G., Rosen, C. A., Goh, W. C., and Haseltine, W. A. (1986). The trans-activator gene of the human T cell lymphotropic virus type III is required for replication. Cell 44, 941-947.
13. Dropulic, B., Lin, N. H., Martin, M. A., and Jeang, K-T. (1992). Functional characterization of a U5 ribozyme: Intracellular suppression of human immunodeficiency virus type 1 expression. J. Virol. 66, 1432-1441.
14. Ensoli, B., Barillan, G., Salahuddin, S. Z., Gallo, R. C., and Wong-Staal, F. (1990). Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 345, 84-86.
15. Ensoli, B., Gendelman, R., Markham, P., Fiorelli, V., Colombini, S., Raffeld, M., Cafaro, A., Chang, H-K., Brady, J. N., and Gallo, R. C. (1994). Synergy between basic fibroblast growth factor and HIV-1 tat protein in induction of Kaposi's sarcoma. Nature 371, 674.
16. Feinberg, M. B., Jarrett, R. F., Aldovini, A., Gallo, R. C., and Wong-Staal, F. (1986). HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA. Cell 46, 806-817.
17. Felber, B. K., Hadzopoulou-Cladaras, M., Cladaras, C., Copeland, T., and Pavlakis, G. N. (1989). Rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proc. Natl. Acad. Sci. USA 86, 1495-1499.
18. Fisher, A. G., Feinberg, M. B., Josephs, S. F., Harper, M. E., Marselle, L. M., Reyes, G., Gonda, M. A., Aldovini, A., Debouk, C., Gallo, R. C., and Wong-Staal, F. (1986). The trans-activator gene of HTLV-III is essential for virus replication. Nature 320, 367-371.
19. Freed, E. O., Delwart, E. L., Buchschacher, G. L., Jr., and Panganiban, A. T. (1992). A mutant in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity. Proc. Natl. Acad. Sci. USA 89, 70-74.
20. Furuta, R. A., Kubota, S., Maki, M., Miyazaki, Y., Hattori, T., and Hatanaka, M. (1995). Use of a human immunodeficiency virus type 1 rev mutant without nucleolar dysfunction as a candidate for potential AIDS therapy. J. Virol. 69, 1591-1599.
21. Gilman, M. (1992). Preparation of cytoplasmic RNA from tissue culture cells. In "Current Protocols in Molecular Biology" (F. M. Ausubel, R. Brent, R. E. Kington, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl, Eds.), pp. 4.1.2-4.1.6. Wiley, New York.
22. Graham, F. L., and Van der Eb, A. J. (1973). A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52, 456.
23. Green, M., Ishino, M., and Loewenstein, P. M. (1989). Mutational analysis of HIV-1 tat minimal domain peptides: Identification of transdominant mutants that suppress HIV-LTR-driven gene expression. Cell 58, 215-223.
24. Hantzopoulos, P., Sullenger, B. A., Ungers, G., and Gilboa, E. (1989). Improved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector. Proc. Natl. Acad. Sci. USA 86, 3519-3523.
25. Hayashi, T., Shioda, T., Iwakura, Y., and Shibuta, H. (1992). RNA packaging signal of human immunodeficiency virus type1. Virology 188, 590-599.
26. Hill, A., and Ploegh, H. (1995). Getting the inside out: The transporter associated with antigen processing (TAP) and the presentation of viral antigen. Proc. Natl. Acad. Sci. USA 92, 341-343.
27. Hirt, B. (1967). Selective extraction of polyoma DNA from infected mouse cell culture. J. Mol. Biol. 26, 365-369.
28. Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M., and Markowitz, M. (1995). Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123-126.
29. Ho, W-Z, Harouse, J. M., Rando, R. F., Gonezol, E., Srinivason, A., and Plotkin, S. A. (1990). Reciprocal enhancement of gene expression and viral replication between human cytomegalovirus and human immunodeficiency virus type 1. J. Gen. Virol. 71, 97-103.
30. Homann, M., Tzortzakaki, S., Rittner, K., Sczakiel, G., and Tabler, M. (1993). Incorporation of the catalytic domain of a hammerhead ribozyme into antisense RNA enhances its inhibitory effect on the replication of human immunodeficiency virus type 1. Nucleic Acids. Res. 21, 2809-2814.
31. Johnson, V. A., and Byington, R. E. (1990). Quantitative assays for virus infectivity. In "Techniques in HIV Research" (A. Aldovini and B. D. Walker, Ed.), pp. 71-76. Stockton Press, New York.
32. Joshi, S., Brunschot, A. V., Asad, S., Elst, I. V. D., Read, S. E., and Bernstein, A. (1991). Inhibition of human immunodeficiency virus type 1 multiplication by antisense and sense RNA expression. J. Virol. 65, 5524-5530.
33. Lee, S. W., Gallardo, H. F., Gilboa, E., and Smith, C. (1994). Inhibition of human immunodeficiency virus type 1 in human T cells by a potent rev response element decoy consisting of the 13-nucleotide minimal rev-binding domain. J. Virol. 68, 8254-8264.
34. Li, C. J., Friedman, D. J., Wang, C., Metelev, V., and Pardee, A. B. (1995). Induction of apoptosis in uninfected lymphocytes by HIV-1 tat protein. Science 268, 429-431.
35. Li, P., and Burrell, C. J. (1992). Synthesis of human immunodeficiency virus DNA in a cell-to cell transmission model. AIDS Res. Hum. Retroviruses 8, 253-259.
36. Lisziewicz, J., Sun, D., Smythe, J., Lusso, P., Lori, F., Louie, A., Markham, P., Rossi, J., Reitz, M., and Gallo, R. C. (1993). Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric tat activation response RNA decoy as a strategy for gene therapy in AIDS. Proc. Natl. Acad. Sci. USA 90, 8000-8004.
37. Lo, K. M. S., Biasolo, M. A., Dehni, G., Palú, G., and Haseltine, W. (1992). Inhibition of replication of HIV-1 by retroviral vectors expressing tat-antisense and anti-tat ribozyme RNA. Virology 190, 176-183.
38. Lu, Y., Stenzel, M., Sodroski, J. G., and Haseltine, W. A. (1989). Effects of long terminal repeat mutations on human immunodeficiency virus type 1 replication. J. Virol. 63, 4115-4119.
39. Maciejewski, J. P., Weichold, F. F., Young, N. S., Cara, A., Zella, D., Reitz, M. S., Jr., and Gallo, R. C. (1995). Intracellular expression of antibody fragments directed against HIV reverse transcriptase prevents HIV infection in vitro. Nat. Med. 1, 667-673.
40. Malim, M. H., Bohnlein, S., Hauber, J., and Cullen, B. R. (1989). Functional dissection of the HIV-1 rev transactivator - derivation of a transdominant repressor of rev function. Cell 58, 205-214.
41. Malim, M. H., Hauber, J., Le, S. Y., Maizel, J. V., and Cullen, B. R. (1989). The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 338, 254-257.
42. Mhashilkar, A. M., Bagley, J., Chen, S. Y., Szilvay, A. M., Heiland, D. G., and Marasco, W. A. (1995). Inhibition of HIV-1 tat-mediated LTRtransactivation and HIV-1 infection by anti-tat single chain intrabodies. EMBO J. 14, 1542-1551.
43. Miller, A. D., and Buttimore, C. (1986). Redesign of retrovirus packaging cell line to avoid recombination leading to helper virus production. Mol. Cell. Biol. 6, 2895-2902.
44. Miller, A. D., and Rosman, G. J. (1989). Improved retroviral vectors for gene transfer and expression. BioTechniques 7, 980-990.
45. Ojwang, J. Q., Hampel, A., Looney, D. J., Wong-Staal, F., and Rappaport, J. (1992). Inhibition of human immunodeficiency virus type 1 expression by a hairpin ribozyme. Proc. Natl. Acad. Sci. USA 89, 10802-10806.
46. Pearson, L., Garcia, J., Wu, F., Modesti, H., Nelson, J., and Gaynor, R. (1990). A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat. Proc. Natl. Acad. Sci. USA 87, 5079-5083.
47. Peng, H., Reinhart, T. A., Retzel, E. F., Staskus, K. A., Zupancic, M., and Haase, A. T. (1995). Single cell transcript analysis of human immunodeficiency virus gene expression in the transition from latent to productive infection. Virology 206, 16-27.
48. Proudfoot, N. J. (1986). Transcriptional interference and termination between duplicated α-globin gene constructs suggests a novel mechanism for gene regulation. Nature 322, 562-565.
49. Rhodes, A., and James, W. (1990). Inhibition of human immunodeficiency virus replication in cell culture by endogenously synthesized antisense RNA. J. Gen. Virol. 71, 1965-1974.
50. Rhodes, A., and James, W. (1991). Inhibition of heterologous strains of HIV by antisense RNA. AIDS 5, 145-151.
51. Rosen, C. A., Sodroski, J. G., and Haseltine, W. (1985). The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat. Cell 41, 813-823.
52. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989). In "Molecular Cloning: A Laboratory Manual," 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
53. Santos, T., and Zasloff, M. A. (1981). Comparative analysis of human chromosomal segments bearing nonallelic dispersed Met-tRNA-i genes. Cell 23, 699-709.
54. Sarver, N., Cantin, E. M., Chang, P. S., Zaia, J. A., Ladne, P. A., Stephens, D. A., and Rossi, J. (1990). Ribozymes as potential anti-HIV-1 therapeutic agents. Science 247, 1222-1225.
55. Sattentau, Q. J., Dalgleish, A. G., Weiss, R. A., and Beverley, P. C. L. (1986). Epitopes of the CD4 antigen and HIV infection. Science 234, 1120-1123.
56. Sczakiel, G., and Pawlita, M. (1991). Inhibition of human immunodeficiency virus type 1 replication in human T cells stably expressing antisense RNA. J. Virol. 65, 468-472.
57. Sczakiel, G., Oppenlénder, M., Rittner, K., and Pawlita, M. (1992). Tat- and Rev-directed antisense RNA expression inhibits and abolishes replication of human immunodeficiency virus type 1:A temporal analysis. J. Virol. 66, 5576-5581.
58. St. Johnston, D. (1995). The intracellular localization of messenger RNAs. Cell 81, 161-170.
59. Sullenger, B. A., Gallardo, H. F., Ungers, G. E., and Gilboa, E. (1990a). Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication. Cell 63, 601-608.
60. Sullenger, B. A., Gallardo, H. F., Ungers, G. E., and Gilboa, E. (1991). Analysis of trans-acting response decoy RNA-mediated inhibition of human immunodeficiency virus type 1 transactivation. J. Virol. 65, 6811-6816.
61. Sullenger, B. A., Lee, T. C., Smith, C. A., Ungers, G. E., and Gilboa, E. (1990b). Expression of chimeric tRNA-antisense transcripts renders NIH 3T3 cells highly resistant to Moloney murine leukemia virus replication. Mol. Cell. Biol. 10, 6512-6523.
62. Sun, L-Q., Warrilow, D., Wang, L., Witherington, G., MacPherson, J., 61nd Symond, G. (1994). Rbozyme-mediated suppression of Moloney murine leukemia virus and human immunodeficiency virus type 1 replication in permissive cell lines. Proc. Natl. Acad. Sci. USA 91, 9715-9719.
63. Trono, D., Feinberg, M. B., and Baltimore, D. (1989). HIV-1 gag mutants can dominantly interfere with the replication of the wild-type virus. Cell 59, 113-120.
64. Viscidi, R. P., Mayor, K., Lederman, H. M., and Frankel, A. D. (1989). Inhibition of antigen-induced lymphocyte proliferation by tat protein from HIV-1. Science 246, 1606-1608.
65. + lymphocyte-derived cell lines conferred by using retroviral vectors expressing an HIV-1 RNA-specific ribozyme. J. Virol. 65, 5531-5534.
66. Wei, X., Ghosh, S. K., Taylor, M. E., Johnson, V. A., Emini, E. A., Dentsch, P., Lifson, J. D., Bonhoeffer, S., Nowak, M. A., Hahn, B. H., Saag, M. S., and Shaw, G. M. (1995). Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373, 117-195.
67. Yamada, O., Yu, M., Yee, J-K., Kraus, G., Looney, D., and Wong-Staal, F. (1994). Intracellular immunization of human T cells with a hairpin ribozyme against human immunodeficiency virus type 1. Gene Ther. 1, 38-45.
68. Yu, M., Leavitt, M. C., Maruyama, M., Yamada, O., Young, D., Ho, A. D., and Wong-Staal, F. (1995). Intracellular immunization of human fetal cord blood stem/progenitor cells with a ribozyme against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 92, 699-703.
69. Yu, M., Ojwang, J., Yamada, O., Hampel, A., Rapapport, J., Looney, D., and Wong-Staal, F. (1993). A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 90, 6340-6344.